Edinburgh Research Explorer

Promotion of proinflammatory interactions between platelets and monocytes by unfractionated heparin

Research output: Contribution to journalArticle

Related Edinburgh Organisations

Open Access permissions

Open

Documents

http://heart.bmj.com/content/92/11/1635
Original languageEnglish
Pages (from-to)1635-8
Number of pages4
JournalHeart
Volume92
Issue number11
DOIs
Publication statusPublished - Nov 2006

Abstract

Objectives: To determine the in vitro effects of unfractionated heparin, fractionated heparin and direct thrombin inhibition on platelet–monocyte aggregation, and to establish the in vivo effects of unfractionated heparin and direct thrombin inhibition on platelet–monocyte aggregates in patients scheduled for percutaneous coronary intervention (PCI).

Design: Platelet–monocyte aggregates were assessed in whole blood from 18 healthy volunteers after the addition of unfractionated heparin (1 U/ml), enoxaparin (0.8 U/ml) or lepirudin (5.6 µg/ml), and in 28 patients scheduled for elective PCI before and after administration of 100 U/kg of unfractionated heparin or 0.75 mg/kg bivalirudin. The influence of P-selectin-mediated platelet–monocyte aggregation was assessed with specific blocking antibodies.

Results: Addition of unfractionated heparin in vitro was associated with a higher level of platelet–monocyte aggregates than in controls (20.1 (1.9)% v 16.2 (1.6)%, respectively, p < 0.001). However, platelet–monocyte aggregation was not affected by enoxaparin or lepirudin (16.9 (2.0)% and 17.0 (2.2)%, respectively, NS). Intravenous unfractionated heparin in vivo also resulted in an increase in platelet–monocyte aggregates (absolute Δ 7.1 (2.7)%, p < 0.01), whereas intravenous bivalirudin had no effect (absolute Δ −1.5 (2.4)%, NS). The addition of P-selectin blockade abolished any increase in platelet–monocyte aggregates associated with heparin.

Conclusions: In vitro and in vivo unfractionated heparin is associated with increased platelet–monocyte aggregation through a P-selectin-dependent mechanism. These findings provide a potential explanation for the superior cardiovascular outcomes associated with fractionated heparins and direct thrombin inhibitors.

    Research areas

  • Adult, Anticoagulants, Cell Aggregation, Enoxaparin, Heparin, Hirudins, Humans, Monocytes, P-Selectin, Peptide Fragments, Platelet Aggregation, Recombinant Proteins, Thrombin

Download statistics

No data available

ID: 8780923